Table 12: Results at Week 24 (LOCF*) in an Active-Controlled Trial of Dapagliflozin Initial Combination Therapy with Metformin HCl Extended-Release in Adults with Type 2 Diabetes Mellitus Dapagliflozin Add-On To Metformin HCl Immediate-Release A total of 546 adult patients with type 2 diabetes mellitus with inadequate glycemic control (HbA1c 7% and 10%) participated in a 24-week, placebo-controlled trial to evaluate dapagliflozin in combination with metformin HCl (NCT00528879)
The answer is simple: Recent Phase 3 trial data showed: Many obesity experts consider these results among the strongest ever reported for a non-surgical obesity treatment
Increased levels of 8-oxodG, a marker of oxidative DNA damage in the immune complex derived DNA, have been found in lymphocytes and serum from SLE patients, reinforcing ROS in disease etiology [40,41]
In fact, concurrent use of Vyvanse and an MAOI within the last 14 days is contraindicated
2017;18(5) 2 Yonsei Med J
When sodium leaves, water usually follows